According to Straits Research, the global bioburden testing market size was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion in 2033, exhibiting a CAGR of 8.5% during the forecast period (2025–2033). The study draws from comprehensive primary interviews with industry experts, verified proprietary databases, and...